[go: up one dir, main page]

TW200611697A - Generally linear effervescent oral fentanyl dosage form and methods of administering - Google Patents

Generally linear effervescent oral fentanyl dosage form and methods of administering

Info

Publication number
TW200611697A
TW200611697A TW094107160A TW94107160A TW200611697A TW 200611697 A TW200611697 A TW 200611697A TW 094107160 A TW094107160 A TW 094107160A TW 94107160 A TW94107160 A TW 94107160A TW 200611697 A TW200611697 A TW 200611697A
Authority
TW
Taiwan
Prior art keywords
methods
administering
dosage form
generally linear
effervescent oral
Prior art date
Application number
TW094107160A
Other languages
Chinese (zh)
Other versions
TWI387466B (en
Inventor
Derek Moe
Vikas Agarwal
Walid Habib
Original Assignee
Cima Labs Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48471142&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW200611697(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US11/026,132 external-priority patent/US7862832B2/en
Application filed by Cima Labs Inc filed Critical Cima Labs Inc
Publication of TW200611697A publication Critical patent/TW200611697A/en
Application granted granted Critical
Publication of TWI387466B publication Critical patent/TWI387466B/en

Links

Classifications

    • Y02W90/11—

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Fentanyl containing dosage forms and methods using same are described. These dosage forms include substantially less fentanyl by weight than know oral formulation and have advantages in terms of cost and side effects. These dosage forms are intended for oral administration of fentanyl across the oral mucosa.
TW94107160A 2004-10-04 2005-03-09 Ordinary linear foaming oral fentanyl (FENTANYL) dosage form and administration method TWI387466B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61566504P 2004-10-04 2004-10-04
US11/026,132 US7862832B2 (en) 2003-12-31 2004-12-30 Generally linear effervescent oral fentanyl dosage form and methods of administering
US11/026,327 US20050142197A1 (en) 2003-12-31 2004-12-30 Generally linear effervescent oral fentanyl dosage form and methods of administering

Publications (2)

Publication Number Publication Date
TW200611697A true TW200611697A (en) 2006-04-16
TWI387466B TWI387466B (en) 2013-03-01

Family

ID=48471142

Family Applications (1)

Application Number Title Priority Date Filing Date
TW94107160A TWI387466B (en) 2004-10-04 2005-03-09 Ordinary linear foaming oral fentanyl (FENTANYL) dosage form and administration method

Country Status (2)

Country Link
AR (1) AR098347A2 (en)
TW (1) TWI387466B (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7858121B2 (en) 2003-12-31 2010-12-28 Cima Labs, Inc. Effervescent oral fentanyl dosage form and methods of administering fentanyl
US7862832B2 (en) 2003-12-31 2011-01-04 Cima Labs, Inc. Generally linear effervescent oral fentanyl dosage form and methods of administering
US7862833B2 (en) 2003-12-31 2011-01-04 Cima Labs, Inc. Effervescent oral opiate dosage forms and methods of administering opiates
US8728441B2 (en) 1998-03-27 2014-05-20 Cephalon, Inc. Sublingual buccal effervescent
US8802130B2 (en) 1998-03-27 2014-08-12 Cephalon, Inc. Sublingual buccal effervescent

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8728441B2 (en) 1998-03-27 2014-05-20 Cephalon, Inc. Sublingual buccal effervescent
US8765100B2 (en) 1998-03-27 2014-07-01 Cephalon, Inc. Transmucosal effervescent
US8802130B2 (en) 1998-03-27 2014-08-12 Cephalon, Inc. Sublingual buccal effervescent
US7858121B2 (en) 2003-12-31 2010-12-28 Cima Labs, Inc. Effervescent oral fentanyl dosage form and methods of administering fentanyl
US7862832B2 (en) 2003-12-31 2011-01-04 Cima Labs, Inc. Generally linear effervescent oral fentanyl dosage form and methods of administering
US7862833B2 (en) 2003-12-31 2011-01-04 Cima Labs, Inc. Effervescent oral opiate dosage forms and methods of administering opiates
US8092832B2 (en) 2003-12-31 2012-01-10 Cephalon, Inc. Generally linear effervescent oral fentanyl dosage form and methods of administering
US8119158B2 (en) 2003-12-31 2012-02-21 Cephalon, Inc. Effervescent oral fentanyl dosage form and methods of administering fentanyl
US8298577B2 (en) 2003-12-31 2012-10-30 Cephalon, Inc. Effervescent oral opiate dosage forms and methods of administering opiates

Also Published As

Publication number Publication date
TWI387466B (en) 2013-03-01
AR098347A2 (en) 2016-05-26

Similar Documents

Publication Publication Date Title
IL176449A0 (en) Generally linear effervescent oral fentanyl dosage form and methods of administering
WO2005065317A3 (en) Effervescent oral fentanyl dosage form
EP1708685A4 (en) Effervescent oral opiate dosage forms and methods of administering opiates
NO20062504L (en) Compositions and dosage forms for improved absorption
UA88464C2 (en) Method of topical methadone administration providing systemic effect
CY1118179T1 (en) PHARMACEUTICAL COMPOSITION
IL196425A0 (en) Pharmaceutical compositions containing ibuprofen and famotidine
TW200633978A (en) 2,3,4,9-tetrahydro-1H-carbazole derivatives as crth2 receptor antagonists
SI1778680T1 (en) Spirocyclic cyclohexane derivatives
SI1730147T1 (en) SUBSTITUTED 1,4,8-TRIAZASPIRO?á4,5?åDECAN-2-ON COMPOUNDS FOR USE IN THE TREATMENT OF OBESITY
TW200509992A (en) Dosage form containing pantoprazole as active ingredient
SG153661A1 (en) Formulation and methods for the treatment of thrombocythemia
WO2009088673A3 (en) Pharmaceutical composition
MX2010004556A (en) Pharmaceutical formulation of clavulanic acid.
DE60329968D1 (en) Dosage forms containing thyroid hormones and their method of preparation
TW200611697A (en) Generally linear effervescent oral fentanyl dosage form and methods of administering
TW200503785A (en) Dosage form containing (S)-pantoprazole as active ingredient
IL179177A (en) Pharmaceutical composition comprising acyclovir and a delivery agent, a dosage unit, use of acyclovir in the preparation of the pharmaceutical composition, use of the pharmaceutical composition in the preparation of a medicament and a method of preparing the pharmaceutical composition
TW200611696A (en) Effervescent oral fentanyl dosage form and methods of administering fentanyl
SE0203817D0 (en) New composition
TW200611686A (en) Effervescent oral opiate dosage forms and methods of administering opiates
PL1663101T3 (en) Administration form and kit for the oral administration of active substances, vitamins and/or nutrients and use thereof
GB0201607D0 (en) Formulation for the administration of medicinal substances
GB0317345D0 (en) Formulation for the administration of medicinal substances
TW200722080A (en) Dosing regimen

Legal Events

Date Code Title Description
MK4A Expiration of patent term of an invention patent